National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Alcohol-Related Emergency Department Visits and Hospitalizations and Their Co-Occurring Drug-Related, Mental Health, and Injury Conditions in the United States: Findings from the 2006–2010 Nationwide Emergency Department Sample (NEDS) and Nationwide Inpatient Sample (NIS) September 2013 National Institutes of Health National Institute on Alcohol Abuse and Alcoholism 5635 Fishers Lane, MSC 9304 Bethesda, MD 20892‑9304 Acknowledgments This publication was developed by...

Wednesday, February 4, 2009

Summary of the 120th Meeting February 4-5, 2009 The National Advisory Council on Alcohol Abuse and Alcoholism convened for its 120th meeting at 5:30 p.m. on February 4, 2009, at the FishersLaneConferenceCenter in Rockville, Maryland, in a closed session. Dr. Abraham Bautista presided over the closed review of grant applications. The NIAAA National Advisory Council reconvened in closed session on...

Friday, February 12, 2016

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM 141st Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM February 12, 2016 The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 141st meeting at 9:03 a.m. on Friday, February 12, 2016, at NIAAA headquarters in Rockville...

Monday, September 16, 2019

U.S. Department of Health and Human Services National Institutes of Health Minutes of the Seventh Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, National Advisory Council on Drug Abuse, and National Cancer Advisory Board May 15, 2019 Bethesda, Maryland Members of the National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA), National Advisory Council on Drug...

Wednesday, June 8, 2011 - Thursday, June 9, 2011

NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Summary of the 127th Meeting June 8-9, 2011 The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 127th meeting at 5:30 p.m. on June 8, 2011, at the Fishers Lane Conference Center in Rockville, Maryland, in closed session for a review of grant applications. The meeting recessed at...

2022 National Conference on Alcohol and Other Substance Use in Women and Girls: Advances in Prevention, Treatment and Recovery October 20-21, 2022 CONFERENCE AGENDA DAY 1: Thursday, October 20, 2022 8:00 a.m.–8:10 a.m. ET Welcome & Introductions Deidra Roach, M.D., Program Director, Treatment, Health Services, and Recovery Branch, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health...

What we do The Clinical NeuroImaging Research Core (CNIRC) serves two functions: Conducting independent addiction neuroimaging and psychophysiological studies and providing expertise in these areas, through collaborations and support to clinical investigators. We are looking to add a post-doctoral researcher to our team. Learn about the position and how to apply. Research interests include: Investigate the neural correlates of cognition...

George Kunos MD. , PhD. Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 2S-24:MSC 9413 Bethesda MD 20892-9413 telephone: +1 301.443.2069 fax: +1 301.480.0257 e-mail: gkunos@mail.nih.gov Mission Statement The Biology and Functions of the Endocannabinoid System Endocannabinoids are lipid-like mediators discovered in the 1 990s that bind to cannabinoid receptors to trigger...

CAPT Joseph R. Hibbeln, MD, Acting Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 3N07:MSC 9410 Bethesda MD 20892-9410 telephone: 301.594.3034 fax: +1 301.402.4617 e-mail: jhibbeln@mail.nih.gov Overview | Lab Members | Alumni | Videos | Projects | Publications No positions for training or employment are available within The Section on Nutritional Neurosciences...

Thursday, December 13, 2012

The National Advisory Council on Alcohol Abuse and Alcoholism, National Advisory Council on Drug Abuse, and National Cancer Advisory Board convened for their first joint meeting at 11:30 a.m. on December 13, 2012. The meeting originated at National Institutes of Health (NIH), Bethesda, Maryland, chaired by Dr. Lawrence A. Tabak, Principal Deputy Director, NIH. National Advisory Council on Alcohol Abuse...

The mission of the lab is to understand the cellular and molecular mechanisms involved in the development and progression of fibrosis, to explore novel therapeutic targets and to develop effective pharmacotherapies for fibrotic disorders of different etiologies, including alcohol use disorders. We are particularly interested in pursuing a multi-target therapeutic approach to improve treatment efficacy by simultaneously engaging multiple pathogenic...

In this "First Steps to Al-Anon Recovery" podcast, you will hear an interview with Dr. George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses the impacts of alcoholism on family members and friends. For more reasons to try Al-Anon, visit al-anon.org. Al-Anon members: Please remember to maintain anonymity in your comments and don't...

The goal of the Laboratory of Biophotonics and Quantum Biology (LBQB) is to develop advanced imaging and spectroscopy techniques for studying protein-protein interaction under physiological conditions and for developing second-generation biosensors. We are particularly interested in developing new tools and approaches using fluorescent proteins for studying proteins that modulate synaptic behavior. Techniques used in LBQB include two-photon laser scanning confocal...

At some time during their lives, more than 30 percent of U.S. adults surveyed in 2001-2002 had met current diagnostic criteria [i] for an alcohol use disorder (AUD), according to an article in the current issue of the Archives of General Psychiatry . Many of those persons never received treatment, and many others did not receive treatment until well after...

What we do The Section on Clinical Genomics and Experimental Therapeutics (CGET) conducts pre-clinical studies and translational clinical studies with focus on genomics and epigenetics related to the pathophysiology and treatment of alcohol use disorders and addictions. The pre-clinical work focuses on identifying molecular mechanisms involved in addictions, utilizing a wide array of methods including human population genetics, genome wide...

Mechanisms for mitochondrial dysfunction and apoptosis in alcoholic and nonalcoholic fatty liver and tissue injury – Dr. Song and his lab members have studied regulations and roles of the two enzymes involved in metabolism of alcohol and acetaldehyde: the ethanol-inducible cytochrome P450 2E1 (CYP2E1) and mitochondrial aldehyde dehydrogenase (ALDH2). In particular, the functional implications of increased CYP2E1 and decreased ALDH2...

Helping Your Patients with Alcohol-Related Problems. Alcohol contributes to more than 200 health conditions and about 99,000 deaths in the U.S. each year. Yet alcohol-related risks often go unaddressed in healthcare settings.

In this "First Steps to Al-Anon Recovery" podcast, you will hear an interview with Dr. Kenneth Warren, Acting Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses current alcoholism research and how it involves family members affected by someone's alcoholism. For more reasons to try Al-Anon, visit al-anon.org. Al-Anon members: Please remember to maintain anonymity...

In this video, you will hear an interview with Dr. Robert Huebner, Director of the Division of Treatment and Recovery Research at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses the treatment options for alcohol use disorders, pertaining to the drinker and to the drinker's family members and friends. For more reasons to try Al-Anon, visit...

The Section on Neuroendocrinology focuses on the endocannabinoid system, which is involved in the regulation of appetite and the metabolism of lipids, and is therefore implicated in obesity, alcoholism and cardiovascular disease. The Section previously provided the first evidence that mice deficient in the cannabinoid receptor CB1 showed reduced food intake following temporary food deprivation. However, the use of rimonabant...